Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
A phase 2 trial of Laser interstitial thermal therapy systems in Glioma & glioblastoma, run by Washington University School of Medicine, not yet recruiting.
Overview
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas is a phase 2 interventional study registered as NCT07620548 by Washington University School of Medicine, with 99 participants planned, started 2026-08-31 and due to reach its primary completion in 2031-02-28. Interventions recorded: NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy, Cemiplimab, Chemotherapy. Conditions recorded: Glioblastoma, Glioblastoma, IDH-wildtype, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype.
Linked to the technology Laser interstitial thermal therapy systems because the registry names it ("neuroblate") among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialOPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
Shares Laser interstitial thermal therapy systems (NeuroBlate, Visualase), Glioma & glioblastoma and the tag pipeline.
- TrialMR Image Guided Therapy in Prostate Cancer
Shares Laser interstitial thermal therapy systems (NeuroBlate, Visualase) and the tag pipeline.
- TrialA Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Shares Cemiplimab and the tag pipeline.
- TrialInjection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)
Shares Glioma & glioblastoma and the tag pipeline.
- TrialA Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Shares Glioma & glioblastoma and the tag pipeline.
- TrialINO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Shares Cemiplimab, Glioma & glioblastoma and the tag pipeline.